• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变携带者会出现肾和肝囊肿。

Mutation Carriers Develop Kidney and Liver Cysts.

机构信息

Departments of Internal Medicine (Nephrology) and.

Departments of Nephrology.

出版信息

J Am Soc Nephrol. 2019 Nov;30(11):2091-2102. doi: 10.1681/ASN.2019030298. Epub 2019 Aug 8.

DOI:10.1681/ASN.2019030298
PMID:31395617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6830805/
Abstract

BACKGROUND

Mutations in or cause typical autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic kidney disease. Dominantly inherited polycystic kidney and liver diseases on the ADPKD spectrum are also caused by mutations in at least six other genes required for protein biogenesis in the endoplasmic reticulum, the loss of which results in defective production of the gene product, the membrane protein polycystin-1 (PC1).

METHODS

We used whole-exome sequencing in a cohort of 122 patients with genetically unresolved clinical diagnosis of ADPKD or polycystic liver disease to identify a candidate gene, , and cell-based assays of PC1 protein maturation to functionally validate it. For further validation, we identified carriers of loss-of-function mutations and noncarrier matched controls in a large exome-sequenced population-based cohort and evaluated the occurrence of polycystic phenotypes in both groups.

RESULTS

Two patients in the clinically defined cohort had rare loss-of-function variants in , which encodes a protein required for addition of specific mannose molecules to the assembling N-glycan precursors in the endoplasmic reticulum lumen. assays showed that inactivation of results in impaired maturation and defective glycosylation of PC1. Seven of the eight (88%) cases selected from the population-based cohort based on mutation carrier state who had abdominal imaging after age 50; seven (88%) had at least four kidney cysts, compared with none in matched controls without mutations.

CONCLUSIONS

is a novel disease gene in the genetically heterogeneous ADPKD spectrum. This study supports the utility of phenotype characterization in genetically-defined cohorts to validate novel disease genes, and provide much-needed genotype-phenotype correlations.

摘要

背景

或中的突变导致典型的常染色体显性多囊肾病(ADPKD),这是最常见的单基因肾脏疾病。ADPKD 谱中显性遗传多囊肾和肝疾病也由至少其他六个基因的突变引起,这些基因对于内质网中蛋白质生物发生是必需的,其丧失导致膜蛋白多囊蛋白-1(PC1)的基因产物的产生缺陷。

方法

我们使用全外显子组测序在 122 名具有遗传上未解决的 ADPKD 或多囊肝病临床诊断的患者队列中鉴定候选基因,以及基于细胞的 PC1 蛋白成熟功能验证。为了进一步验证,我们在大型外显子组测序的基于人群的队列中鉴定了 功能丧失突变的携带者和非携带者匹配对照,并评估了两组中多囊表型的发生。

结果

临床定义队列中的两名患者具有罕见的功能丧失变体,该基因编码一种蛋白质,该蛋白质对于将特定的甘露糖分子添加到内质网腔中组装的 N-聚糖前体中是必需的。细胞测定表明,的失活导致 PC1 的成熟受损和糖基化缺陷。基于突变携带者状态从基于人群的队列中选择的 8 个病例中的 7 个(88%)在 50 岁后进行了腹部成像,与没有 突变的匹配对照相比,其中 7 个(88%)有至少四个肾囊肿。

结论

是遗传异质性 ADPKD 谱中一个新的疾病基因。这项研究支持在遗传定义的队列中通过表型特征来验证新疾病基因的实用性,并提供急需的基因型-表型相关性。

相似文献

1
Mutation Carriers Develop Kidney and Liver Cysts.突变携带者会出现肾和肝囊肿。
J Am Soc Nephrol. 2019 Nov;30(11):2091-2102. doi: 10.1681/ASN.2019030298. Epub 2019 Aug 8.
2
Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.ALG9 杂合性与常染色体显性多囊肝病相关。
Genes (Basel). 2023 Sep 2;14(9):1755. doi: 10.3390/genes14091755.
3
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.单等位基因致病性 ALG5 变异导致非典型多囊肾病和间质纤维化。
Am J Hum Genet. 2022 Aug 4;109(8):1484-1499. doi: 10.1016/j.ajhg.2022.06.013. Epub 2022 Jul 26.
4
Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.通过全外显子组测序鉴定和分析沙特患者慢性肾脏病(CKD)和常染色体显性多囊肾病(ADPKD)中的新型突变。
Medicina (Kaunas). 2022 Nov 16;58(11):1657. doi: 10.3390/medicina58111657.
5
Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.常染色体显性遗传多囊肾病临床人群外显子组测序。
JAMA. 2022 Dec 27;328(24):2412-2421. doi: 10.1001/jama.2022.22847.
6
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.编码葡萄糖苷酶IIα亚基的GANAB基因突变导致常染色体显性多囊肾和肝病。
Am J Hum Genet. 2016 Jun 2;98(6):1193-1207. doi: 10.1016/j.ajhg.2016.05.004.
7
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.单等位基因 IFT140 致病性变异是常染色体显性多囊肾病谱表型的一个重要原因。
Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9.
8
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.人群测序估算多囊肾病和多囊肝病的患病率。
J Am Soc Nephrol. 2018 Oct;29(10):2593-2600. doi: 10.1681/ASN.2018050493. Epub 2018 Aug 22.
9
Exome sequencing of Saudi Arabian patients with ADPKD.对沙特阿拉伯 ADPKD 患者进行外显子组测序。
Ren Fail. 2019 Nov;41(1):842-849. doi: 10.1080/0886022X.2019.1655453.
10
Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.基因型对常染色体显性多囊肾病中多囊肝病严重程度及体积进展的影响。
Nephrol Dial Transplant. 2016 Jun;31(6):952-60. doi: 10.1093/ndt/gfw008. Epub 2016 Feb 29.

引用本文的文献

1
Glycosylation in kidney diseases.肾脏疾病中的糖基化作用。
Precis Clin Med. 2025 Jul 11;8(3):pbaf017. doi: 10.1093/pcmedi/pbaf017. eCollection 2025 Sep.
2
Rare Complication of Renal Torsion in Autosomal Dominant Polycystic Kidney Disease following an Intraperitoneal Kidney Transplantation.腹膜内肾移植后常染色体显性多囊肾病中肾扭转的罕见并发症
Case Rep Nephrol Dial. 2025 Jun 25;15(1):150-160. doi: 10.1159/000546881. eCollection 2025 Jan-Dec.
3
Using Large Genomic Biobanks to Generate Insights into Genetic Kidney Disease.

本文引用的文献

1
Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中肾囊肿上皮的体细胞突变。
J Am Soc Nephrol. 2018 Aug;29(8):2139-2156. doi: 10.1681/ASN.2017080878. Epub 2018 Jul 24.
2
Profiling and Leveraging Relatedness in a Precision Medicine Cohort of 92,455 Exomes.在一个包含 92455 个外显子组的精准医学队列中进行相关分析和利用。
Am J Hum Genet. 2018 May 3;102(5):874-889. doi: 10.1016/j.ajhg.2018.03.012.
3
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
利用大型基因组生物样本库深入了解遗传性肾脏疾病。
Semin Nephrol. 2025 Jul 11:151651. doi: 10.1016/j.semnephrol.2025.151651.
4
Effects of Pregnancy on Liver and Kidney Cyst Growth Rates in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.妊娠对常染色体显性遗传性多囊肾病患者肝脏和肾脏囊肿生长速率的影响:一项初步研究
J Clin Med. 2025 May 24;14(11):3688. doi: 10.3390/jcm14113688.
5
Ciliary Ion Channels in Polycystic Kidney Disease.多囊肾病中的睫状体离子通道
Cells. 2025 Mar 19;14(6):459. doi: 10.3390/cells14060459.
6
Genetic analysis of autosomal dominant polycystic kidney disease in Iranian families: a combined Sanger and next-generation sequencing study.伊朗家族中常染色体显性多囊肾病的基因分析:一项桑格测序与新一代测序相结合的研究
J Appl Genet. 2025 Feb 14. doi: 10.1007/s13353-024-00937-1.
7
Exploring the location patterns and clinical characteristics of isolated simple renal cysts: insights from a multicenter retrospective study.探索孤立性单纯肾囊肿的位置模式和临床特征:一项多中心回顾性研究的见解
World J Urol. 2025 Feb 6;43(1):105. doi: 10.1007/s00345-025-05465-z.
8
Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants.与单等位基因ALG8和ALG9致病变体相关的囊性表型特征
J Am Soc Nephrol. 2025 Jun 1;36(6):1056-1071. doi: 10.1681/ASN.0000000613. Epub 2025 Feb 3.
9
Heterozygous pathogenic STT3A variation leads to dominant congenital glycosylation disorders and functional validation in zebrafish.杂合致病性STT3A变异导致显性先天性糖基化障碍并在斑马鱼中进行功能验证。
Orphanet J Rare Dis. 2025 Jan 31;20(1):46. doi: 10.1186/s13023-025-03557-y.
10
Phenotypic outcomes of PKD1 compared with non-PKD1 genetically confirmed autosomal dominant polycystic kidney disease.与经基因确认的非PKD1型常染色体显性多囊肾病相比,PKD1的表型结果。
J Nephrol. 2025 Jan 30. doi: 10.1007/s40620-024-02184-3.
DNAJB11 的单等位基因突变导致非典型常染色体显性多囊肾病。
Am J Hum Genet. 2018 May 3;102(5):832-844. doi: 10.1016/j.ajhg.2018.03.013. Epub 2018 Apr 26.
4
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.评估 ACMG/AMP 临床变异解读指南中使用的计算机算法。
Genome Biol. 2017 Nov 28;18(1):225. doi: 10.1186/s13059-017-1353-5.
5
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.常染色体显性遗传多囊肾病和肝病的遗传复杂性。
J Am Soc Nephrol. 2018 Jan;29(1):13-23. doi: 10.1681/ASN.2017050483. Epub 2017 Oct 16.
6
ALG9-CDG: New clinical case and review of the literature.ALG9 - 先天性糖基化障碍:新的临床病例及文献综述
Mol Genet Metab Rep. 2017 Sep 6;13:55-63. doi: 10.1016/j.ymgmr.2017.08.004. eCollection 2017 Dec.
7
Isolated polycystic liver disease genes define effectors of polycystin-1 function.孤立性多囊肝病基因定义了多囊蛋白-1功能的效应器。
J Clin Invest. 2017 Sep 1;127(9):3558. doi: 10.1172/JCI96729.
8
Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2.由磷酸甘露糖变位酶2启动子突变引起的多囊肾病伴高胰岛素性低血糖症
J Am Soc Nephrol. 2017 Aug;28(8):2529-2539. doi: 10.1681/ASN.2016121312. Epub 2017 Apr 3.
9
Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.50726 例全外显子组序列中的功能变体的分布和临床影响:DiscovEHR 研究。
Science. 2016 Dec 23;354(6319). doi: 10.1126/science.aaf6814.
10
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169. doi: 10.1093/nar/gkw1099. Epub 2016 Nov 29.